Rachel E. Haurwitz serves as Executive at Intellia Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Rachel E. Haurwitz has executed 13 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 12, 2024 involved receiving (via award) 58,178 shares valued at $0.
Rachel E. Haurwitz currently holds 87,615 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rachel E. Haurwitz has been a net neutral trader of NTLA stock. They have purchased $0 and sold $0 worth of shares.
Rachel E. Haurwitz's most recent insider trade was on Jun 12, 2024, when they sold 58,178 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 14, 2023 | SEER | $0 | Award | 23,443 | $N/A | Discretionary |
| Jun 8, 2023 | CRBU | $29.6K | Option Exercise | 10,000 | $2.96 | Discretionary |
| Mar 20, 2023 | CRBU | $29.6K | Option Exercise | 10,000 | $2.96 | Discretionary |
| Jun 15, 2022 | SEER | $0 | Award | 5,994 | $N/A | Discretionary |
| May 9, 2022 | CRBU | $29.6K | Option Exercise | 10,000 | $2.96 | Discretionary |
| Jan 26, 2022 | CRBU | $29.6K | Option Exercise | 10,000 | $2.96 | Discretionary |
| Jan 26, 2022 | CRBU | $29.6K | Option Exercise | 10,000 | $2.96 | Discretionary |
| Sep 27, 2021 | CRBU | $0 | Gift | 3,349,395 | $N/A | Discretionary |
| Sep 27, 2021 | CRBU | $0 | Gift | 3,349,395 | $N/A | Discretionary |
| May 11, 2016 | NTLA | $0 | Conversion | 5,244,234 | $N/A | Discretionary |
| May 11, 2016 | NTLA | $0 | Conversion | 174,806 | $N/A | Discretionary |